BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20524872)

  • 1. Diphencyprone and topical tacrolimus as two topical immunotherapeutic modalities. Are they effective in the treatment of alopecia areata among Egyptian patients? A study using CD4, CD8 and MHC II as markers.
    Hunter N; Shaker O; Marei N
    J Dermatolog Treat; 2011 Feb; 22(1):2-10. PubMed ID: 20524872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of alopecia areata in C3H/HeJ mice with the topical immunosuppressant FK506 (Tacrolimus).
    Freyschmidt-Paul P; Ziegler A; McElwee KJ; Happle R; Kissling S; Sundberg JP; Hoffmann R
    Eur J Dermatol; 2001; 11(5):405-9. PubMed ID: 11525945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
    Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
    Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone.
    Wasyłyszyn T; Kozłowski W; Zabielski SL
    Arch Dermatol Res; 2007 Aug; 299(5-6):231-7. PubMed ID: 17530266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata.
    Sotiriadis D; Patsatsi A; Lazaridou E; Kastanis A; Vakirlis E; Chrysomallis F
    Clin Exp Dermatol; 2007 Jan; 32(1):48-51. PubMed ID: 17004987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA).
    Galadari I; Rubaie S; Alkaabi J; Galadari H
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):397-401. PubMed ID: 14768526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series.
    Durdu M; Özcan D; Baba M; Seçkin D
    J Am Acad Dermatol; 2015 Apr; 72(4):640-50. PubMed ID: 25653027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic cyclosporine and low-dose prednisone in the treatment of chronic severe alopecia areata: a clinical and immunopathologic evaluation.
    Shapiro J; Lui H; Tron V; Ho V
    J Am Acad Dermatol; 1997 Jan; 36(1):114-7. PubMed ID: 8996277
    [No Abstract]   [Full Text] [Related]  

  • 9. Topical tacrolimus in alopecia areata.
    Price VH; Willey A; Chen BK
    J Am Acad Dermatol; 2005 Jan; 52(1):138-9. PubMed ID: 15627095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diphencyprone in the treatment of alopecia areata.
    Happle R; Hausen BM; Wiesner-Menzel L
    Acta Derm Venereol; 1983; 63(1):49-52. PubMed ID: 6191489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata.
    Cotellessa C; Peris K; Caracciolo E; Mordenti C; Chimenti S
    J Am Acad Dermatol; 2001 Jan; 44(1):73-6. PubMed ID: 11148480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diphencyprone immunotherapy alters anti-hair follicle antibody status in patients with alopecia areata.
    Tobin DJ; Gardner SH; Lindsey NJ; Hoffmann R; Happle R; Freyschmidt-Paul P
    Eur J Dermatol; 2002; 12(4):327-34. PubMed ID: 12095876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alopecia areata: topical immunotherapy treatment with diphencyprone.
    Avgerinou G; Gregoriou S; Rigopoulos D; Stratigos A; Kalogeromitros D; Katsambas A
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):320-3. PubMed ID: 18005118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical diphencyprone for alopecia areata: evaluation of 48 cases after 30 months' follow-up.
    Gordon PM; Aldrige RD; McVittie E; Hunter JA
    Br J Dermatol; 1996 May; 134(5):869-71. PubMed ID: 8736327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DPCP for the treatment of alopecia areata.
    Bolduc C; Shapiro J
    Skin Therapy Lett; 2000; 5(5):3-4. PubMed ID: 10854342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of alopecia areata with diphencyprone].
    Suditu G; Toma A; Voiculescu M
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):760-2. PubMed ID: 12092234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year experience in the treatment of alopecia areata with DPC.
    El-Zawahry BM; Bassiouny DA; Khella A; Zaki NS
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):264-9. PubMed ID: 19744175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful immunsuppression in childhood alopecia areata.
    Sauerbrey A
    Klin Padiatr; 2011 Jul; 223(4):244-5. PubMed ID: 21509708
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of alopecia areata with diphenylcyclopropenone].
    Kietzmann H; Hardung H; Christophers E
    Hautarzt; 1985 Jun; 36(6):331-5. PubMed ID: 3160683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hair growth in patients alopecia areata totalis after treatment with simvastatin and ezetimibe.
    Ali A; Martin JM
    J Drugs Dermatol; 2010 Jan; 9(1):62-4. PubMed ID: 20120427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.